These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23134020)

  • 1. [Initial therapy for multiple myeloma].
    Shimizu K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():589-96. PubMed ID: 23134020
    [No Abstract]   [Full Text] [Related]  

  • 2. Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?
    Mohty M; Richardson PG; McCarthy PL; Attal M
    Bone Marrow Transplant; 2015 Aug; 50(8):1024-9. PubMed ID: 25893452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VI. Autologous stem cell transplantation and maintenance therapy.
    Moreau P
    Hematol Oncol; 2013 Jun; 31 Suppl 1():42-6. PubMed ID: 23775648
    [No Abstract]   [Full Text] [Related]  

  • 4. Thalidomide maintenance therapy for patients with multiple myeloma: meta-analysis.
    Kagoya Y; Nannya Y; Kurokawa M
    Leuk Res; 2012 Aug; 36(8):1016-21. PubMed ID: 22579366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
    Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
    Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontline therapy in multiple myeloma: fast start for a long game.
    Patriarca F
    Lancet Haematol; 2019 Dec; 6(12):e600-e601. PubMed ID: 31624046
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimizing multiple myeloma treatment: conclusions.
    Palumbo A
    Leuk Res; 2012 Nov; 36 Suppl 1():S44-5. PubMed ID: 23176724
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in multiple myeloma: a Korean perspective.
    Hong J; Lee JH
    Korean J Intern Med; 2016 Sep; 31(5):820-34. PubMed ID: 27604794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma.
    Offidani M; Corvatta L; Polloni C; Gentili S; Mele A; Rizzi R; Catarini M; Caraffa P; Samori A; Blasi N; Ferranti M; Malerba L; Brunori M; Leoni P
    Ann Hematol; 2011 Dec; 90(12):1449-56. PubMed ID: 21437586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [III. Induction chemotherapy for multiple myeloma].
    Terui Y
    Gan To Kagaku Ryoho; 2013 May; 40(5):594-5. PubMed ID: 23957067
    [No Abstract]   [Full Text] [Related]  

  • 11. Locally advanced non-small cell lung cancer: what is the optimal concurrent chemoradiation regimen?
    Videtic GM
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS32-7. PubMed ID: 22614963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the therapy of multiple myelomas--initial induction therapy (MP, IFN alpha, steroid pulse) and maintenance therapy (VMP, MP continuous, VEP, MCNU)].
    Tanaka H; Kawano M; Iwato K; Asaoku H; Tanabe O; Ishikawa H; Nobuyoshi M; Sakai A; Kuramoto A
    Rinsho Ketsueki; 1992 May; 33(5):655-61. PubMed ID: 1630017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].
    Adachi T; Hasegawa M; Asano K; Sezaki T; Ishii H; Takahashi I; Kimura I
    Rinsho Ketsueki; 1983 Apr; 24(4):440-7. PubMed ID: 6887544
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple myeloma: a therapeutic enigma.
    Hoogstraten B
    Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.
    Palumbo A; Gay F; Falco P; Crippa C; Montefusco V; Patriarca F; Rossini F; Caltagirone S; Benevolo G; Pescosta N; Guglielmelli T; Bringhen S; Offidani M; Giuliani N; Petrucci MT; Musto P; Liberati AM; Rossi G; Corradini P; Boccadoro M
    J Clin Oncol; 2010 Feb; 28(5):800-7. PubMed ID: 20048187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial.
    Sonneveld P; Schmidt-Wolf IG; van der Holt B; El Jarari L; Bertsch U; Salwender H; Zweegman S; Vellenga E; Broyl A; Blau IW; Weisel KC; Wittebol S; Bos GM; Stevens-Kroef M; Scheid C; Pfreundschuh M; Hose D; Jauch A; van der Velde H; Raymakers R; Schaafsma MR; Kersten MJ; van Marwijk-Kooy M; Duehrsen U; Lindemann W; Wijermans PW; Lokhorst HM; Goldschmidt HM
    J Clin Oncol; 2012 Aug; 30(24):2946-55. PubMed ID: 22802322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
    Azam L; Delamore IW
    Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemotherapy of multiple bone myeloma. Prognostic features and response criteria (First part) (author's transl)].
    Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
    Sem Hop; 1979 Sep 8-15; 55(27-30):1267-70. PubMed ID: 228397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of treatment for multiple myeloma].
    Tsuchiya J
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):1911-20. PubMed ID: 7184381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of multiple bone myeloma. Historical and present day aspects. (Second part) (author's transl)].
    Bataille R; Morlock G; Rosenberg F; Sany J; Serre H
    Sem Hop; 1979 Sep 18-25; 55(31-32):1377-82. PubMed ID: 228415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.